The phrase "an adverse interaction" is correct and usable in written English.
It can be used in contexts discussing negative effects or conflicts, particularly in medical, scientific, or social situations.
Example: "The patient experienced an adverse interaction between the two medications, leading to severe side effects."
Alternatives: "a negative interaction" or "an unfavorable interaction".
Lastly, doctors would not be immune from suit if they have failed to ask their patients what herbs or supplements they are taking before prescribing medicine that could lead to an adverse interaction.
But don't just take two, because getting double doses of other vitamins and minerals can be unsafe (for example, too much vitamin A as retinol can cause hair loss and diarrhea and is associated with hip and other bone fractures, possibly due to an adverse interaction with vitamin D).
In more serious cases, an adverse interaction can cause life-threatening complications.
Each individual has a unique response to an adverse interaction, but Reilly says patients should contact a pharmacist or physician if they experience a rash or difficulty breathing.
Furthermore, unlike the benzodiazepines, JNJ-5234801 does not have an adverse interaction with ethanol even at doses 20 to 40 times the minimal effective dose in the rat elevated plus maze (MED=1.0 mg/kg, p.o.).
Yet, a case of a 71-year-old man indicated that an adverse interaction between warfarin and SMY resulted in cerebral bleeding [ 170].
He also weaned off the other medications he was taking to avoid any adverse interactions or confounding effects.
From all adverse interactions, we extracted the adverse drug interactions of SCZ drugs including both interactions among SCZ drugs and interactions between SCZ drugs and non-SCZ drugs.
Though muscle pain and myositis is an issue in statin/fibrate treatment, adverse interaction appears to occur to a significantly greater extent when gemfibrozil is administered.
In addition, practitioners should avoid prescribing multiple-drug therapies that have overlapping pharmacodynamics or that may have an adverse pharmacokinetic interaction.
Therapies which have overlapping pharmacodynamics or that may have an adverse pharmacokinetic interaction, such as metabolic inhibitors, should not be combined.
